News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • UnitedHealth beat Q3 and raised 2026 guidance to at least $20.50, driven by improved medical cost management.
  • Phillips 66's $6.4B free cash flow supports dividends and buybacks, reinforcing income investor demand.
  • Toast's operating leverage is converting revenue growth into profits, prompting analysts to recommend a 45-day long trade.
  • Aktis Oncology's clinical imaging and cash runway support a long-biased swing trade ahead of upcoming clinical milestones.
  • Multiple analyst trade ideas across healthcare, energy, payments, and biotech point to a risk-on bias in short-term trading.

Latest Articles

BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting

BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting

BioCardia, Inc. announced its presentation of the CardiAMP HF II trial design at the 2026 Heart Failure Society of America Annual Scientific Meeting. The multicenter, double-blind randomized controlled trial evaluates high dose autologous cell therapy for ischemic heart failure patients with reduced ejection fraction. The trial aims to support regu…

Lucas GC Limited Announces 1H 2026 Financial Results: Revenue at US$35.74 million with Increases in Gross Margin

Lucas GC Limited Announces 1H 2026 Financial Results: Revenue at US$35.74 million with Increases in Gross Margin

Lucas GC Limited, a Nasdaq-listed AI-driven PaaS company targeting the HR and insurance sectors, announced its 1H 2026 results showing a 36.6% revenue decline to US$35.7 million largely due to decreases in outsourcing and recruitment services amidst macroeconomic headwinds. However, the company improved gross margin by 1.7% to 35.4% and increased n…

Onfolio Holdings Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement

Onfolio Holdings Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement

Onfolio Holdings Inc. has received an extension from Nasdaq until November 23, 2026, to regain compliance with the minimum stockholders' equity requirement of $2.5 million. The company previously failed to meet this standard and did not satisfy alternative compliance measures. Nasdaq will continue to monitor Onfolio's progress, with potential delis…

Optimi Health to Present at the ThinkEquity Conference

Optimi Health to Present at the ThinkEquity Conference

Optimi Health, a commercial-stage pharmaceutical company specializing in regulated psychedelic drug products for mental health therapies, announced that it will present at the ThinkEquity Conference on October 15, 2026. The presentation will cover a corporate overview and provide opportunities for one-on-one investor meetings.

Coffee Holding Co., Inc. Announces Share Repurchase Program

Coffee Holding Co., Inc. Announces Share Repurchase Program

Coffee Holding Co., Inc. (NASDAQ: JVA) announced a new share repurchase program authorizing up to $2.5 million to buy back its common stock, funded through cash and operational cash flow. The company highlighted strengthened fundamentals, improved gross margins, and operational efficiencies. CEO Andrew Gordon emphasized the stock price undervaluati…

WidePoint to Present at the LD Micro 20th Annual Main Event on Tuesday, October 20, 2026 at 4:00 p.m. Pacific Time

WidePoint to Present at the LD Micro 20th Annual Main Event on Tuesday, October 20, 2026 at 4:00 p.m. Pacific Time

WidePoint Corporation, a leading provider of secure mobile management solutions, announced it will present at the LD Micro 20th Annual Main Event in Los Angeles on October 20, 2026, and hold one-on-one meetings throughout the conference. The presentation will also be available online, emphasizing the company's ongoing engagement with investors and …

Algorhythm Introduces Azure P2P™, a Renewable Power Generation Process Designed to Deliver Around-the-Clock Power

Algorhythm Introduces Azure P2P™, a Renewable Power Generation Process Designed to Deliver Around-the-Clock Power

Algorhythm Holdings, Inc. announced the introduction of Azure P2P™, a pyrolysis-to-power technology developed by its subsidiary Azure Holdings. The process converts low-value forest wood into dispatchable renewable electricity capable of delivering nearly 100% uptime, addressing reliability challenges of intermittent renewable sources. Targeting la…

LPL Financial Welcomes Legacy Financial Group

LPL Financial Welcomes Legacy Financial Group

LPL Financial announced that Legacy Financial Group, led by financial advisor Brad Jerome and managing approximately $175 million in assets, has joined LPL's broker-dealer and Registered Investment Advisor platforms. The move aims to support Legacy Financial Group's growth with LPL's robust technology, investment platforms, and advisor support. The…

Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform

Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform

Artelo Biosciences announced it will deliver its first-ever company presentation at BIO-Europe 2026, showcasing clinical and nonclinical data on its novel FABP5 inhibitor ART26.12. The company highlighted the drug's favorable safety profile, dosing flexibility, and potential efficacy in treating chemotherapy-induced peripheral neuropathy and osteoa…

Tessera: Zorronet Reports Growing Operational Deployments of Its Natural-Language AI Platform in Defense and Critical Infrastructure

Tessera: Zorronet Reports Growing Operational Deployments of Its Natural-Language AI Platform in Defense and Critical Infrastructure

Tessera Defense and Homeland Security's subsidiary, Zorronet Ltd., reports significant operational deployments of its advanced AI intelligence platform integrating natural-language processing, video analytics, and no-code tools. The platform is being adopted by customers in critical infrastructure, defense, public safety, transportation, and energy…

WISeSat.Space to Ring the Nasdaq Opening Bell on October 9 and Highlight Secure Space Infrastructure Strategy at  Convene Quantum Space Security Roundtable

WISeSat.Space to Ring the Nasdaq Opening Bell on October 9 and Highlight Secure Space Infrastructure Strategy at Convene Quantum Space Security Roundtable

WISeSat.Space Holdings Corp. (NASDAQ: SAIQ) will ring the Nasdaq Opening Bell on October 9, 2026, to mark its listing and outline its strategy for developing quantum-resilient space communication infrastructure. The company will also host a Quantum Space Security Roundtable featuring experts in space, quantum tech, and cybersecurity to discuss prot…

Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA

Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA

Clearmind Medicine Inc. announced that it has submitted recommendations to the U.S. FDA advocating for new regulatory pathways and broader patient access to non-hallucinogenic psychedelic-derived neuroplastogens for treating Alcohol Use Disorder and other neuropsychiatric conditions. The company highlighted promising clinical trial results from Yal…

Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

Wellspect HealthCare, a subsidiary of Dentsply Sirona, announced that its Surity™ portfolio of urinary management products is now eligible for traditional Medicare reimbursement for medically necessary cases. This milestone expands access to non-invasive urinary incontinence solutions for over 13 million affected patients in the U.S., reducing barr…

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region

OneMedNet Corporation announced a strategic partnership with Mediplexus, a Korean healthcare data company, to distribute its U.S.-sourced Real World Data in Korea and the broader Asia Pacific region. This agreement marks OneMedNet's 11th channel partner and aims to broaden collaborative data applications for Korean biopharma, medtech, and medical A…

Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million

Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million

Ultragenyx Pharmaceutical announced a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million. The PRV was granted following FDA approval of Genelycos™, a treatment for glycogen storage disease type Ia. The sale is expected to provide non-dilutive capital to advance Ultragenyx's pipeline and support pr…